Why the study?
Understanding the pathophysiology and altered hemodynamics of bicuspid aortic valve disease is key for diagnosis, risk stratification, and selecting among evolving treatment strategies.
This review provides an updated overview of the causes, diagnosis, risk stratification, and treatment strategies for bicuspid aortic valve disease, highlighting transcatheter aortic valve implantation as an emerging alternative option.
May guide bicuspid aortic valve decisions; leaves open need for dedicated randomized TAVI trials.
The most common congenital heart disease is the bicuspid aortic valve. Understanding the pathophysiology and the altered hemodynamics is a key component for the diagnosis, risk stratification and treatment. Among others, aortic valve stenosis is the most common complication. Treatment strategies vary depending on the severity of the disease, particularly the dilation of the aorta playing a major role. Together with valve replacement, transcatheter aortic valve implantation is now considered as an alternative option with good results. With this review we would like to discuss the causes, diagnostic methods, risk stratification and treatment strategies of the bicuspid aortic valve.
No takes yet. Share an insight, caveat, or question.
Sakellaropoulos et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: